Guotai Haitong Securities: Innovation drug investment and financing are warming up, and the clinical CRO industry is expected to continue to improve in prosperity

Source: Finance China Society On February 6, Guotai Haitong Securities published a research report analyzing that, against the backdrop of a rebound in innovative drug investment, financing, and R&D activities, a regulatory focus on efficiency, and the upgrade of clinical execution models towards data-driven and intelligent systems, the demand for clinical CROs has a foundation for recovery, and industry prosperity is expected to gradually improve. Innovation… Web link

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)